Ohio State University - Arthur G James Cancer Hospital & Richard J Solove Research Institute

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer	HER2 positive breast carcinoma, Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, male breast carcinoma, neoplasm, skin disorder	Active, not recruiting	Phase 2	2026-03-06		NCT03384914

Clinical trials